Condensed Consolidated Balance Sheets - USD ($)	Mar. 31, 2024	Dec. 31, 2023
Current Assets
Cash	$ 6,875	$ 50,433
Other current assets	12,597	38,818
Total Current Assets	19,472	89,251
Non-current assets
Plant and equipment	6,484	7,027
Notes receivable	161,615
Security deposit	5,000	5,000
Equity method investment	703,954	703,938
Total Non-Current Assets	877,053	715,965
Total Assets	896,525	805,216
Current Liabilities
Accounts payable	2,307,053	2,023,375
Federal relief loans – current portion	9,309	9,369
Notes payable	1,086,374	1,062,007
Convertible debt, net of unamortized discount of $432,702 and $687,503, respectively	4,393,479	3,704,280
Derivative liability	618,255	1,434,196
Total Current Liabilities	8,414,470	8,233,227
Non-Current Liabilities
Federal relief loans	150,000	150,000
Total Non-Current Liabilities	150,000	150,000
Total Liabilities	8,564,470	8,383,227
Equity (Deficit)
Preferred stock, $0.0001 par value, 25,000,000 shares authorized, and 0 shares issued and outstanding as of March 31, 2024 and December 31, 2023.
Common stock, $0.0001 par value; 750,000,000 shares authorized, 13,819,889 issued and outstanding as of March 31, 2024 and December 31, 2023.	1,382	1,382
Additional paid-in-capital	50,897,756	50,656,225
Accumulated deficit	(58,567,083)	(58,235,618)
Total Equity (Deficit)	(7,667,945)	(7,578,011)
Total Liabilities and Equity (Deficit)	$ 896,525	$ 805,216